Q3 EPS Estimates for W.R. Berkley Lifted by Zacks Research

W.R. Berkley Corporation (NYSE:WRB) – Equities researchers at Zacks Research lifted their Q3 2026 EPS estimates for W.R. Berkley in a research note issued to investors on Tuesday, June 24th. Zacks Research analyst T. De now anticipates that the insurance provider will post earnings of $1.15 per share for the quarter, up from their prior forecast of $1.14. The consensus estimate for W.R. Berkley’s current full-year earnings is $4.33 per share.

W.R. Berkley (NYSE:WRB) last issued its earnings results on Monday, April 21st. The insurance provider reported $1.01 earnings per share for the quarter, missing the consensus estimate of $1.08 by ($0.07). The business had revenue of $3.01 billion for the quarter, compared to analyst estimates of $3.01 billion. W.R. Berkley had a net margin of 12.43% and a return on equity of 19.66%.

Several other research firms also recently commented on WRB. Barclays raised their target price on W.R. Berkley from $52.00 to $62.00 and gave the stock an “underweight” rating in a research report on Friday, April 11th. Wells Fargo & Company increased their target price on shares of W.R. Berkley from $69.00 to $70.00 and gave the stock an “equal weight” rating in a research report on Tuesday, April 22nd. Keefe, Bruyette & Woods upped their price objective on shares of W.R. Berkley from $65.00 to $75.00 and gave the stock a “market perform” rating in a research note on Monday, May 19th. Truist Financial lifted their target price on shares of W.R. Berkley from $68.00 to $80.00 and gave the company a “buy” rating in a research note on Thursday, April 3rd. Finally, Bank of America restated a “neutral” rating and set a $74.00 price target (up from $73.00) on shares of W.R. Berkley in a research report on Tuesday, April 1st. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat, W.R. Berkley presently has a consensus rating of “Hold” and an average target price of $70.64.

W.R. Berkley Stock Up 0.9%

NYSE WRB opened at $72.43 on Thursday. W.R. Berkley has a 1-year low of $51.41 and a 1-year high of $76.38. The company has a market capitalization of $27.48 billion, a price-to-earnings ratio of 16.80, a PEG ratio of 2.46 and a beta of 0.42. The stock’s 50 day moving average is $72.58 and its two-hundred day moving average is $65.56. The company has a current ratio of 0.36, a quick ratio of 0.36 and a debt-to-equity ratio of 0.32.

W.R. Berkley Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Monday, June 23rd will be given a dividend of $0.09 per share. The ex-dividend date of this dividend is Monday, June 23rd. This is an increase from W.R. Berkley’s previous quarterly dividend of $0.08. This represents a $0.36 dividend on an annualized basis and a yield of 0.50%. W.R. Berkley’s dividend payout ratio is presently 8.35%.

Institutional Investors Weigh In On W.R. Berkley

Several institutional investors have recently modified their holdings of WRB. Spectrum Wealth Counsel LLC bought a new position in W.R. Berkley in the first quarter valued at approximately $29,000. Garde Capital Inc. bought a new position in shares of W.R. Berkley in the 1st quarter worth $30,000. Optiver Holding B.V. grew its position in shares of W.R. Berkley by 107.3% during the 4th quarter. Optiver Holding B.V. now owns 427 shares of the insurance provider’s stock worth $25,000 after buying an additional 221 shares during the period. N.E.W. Advisory Services LLC bought a new stake in shares of W.R. Berkley in the 1st quarter valued at about $36,000. Finally, Keystone Global Partners LLC acquired a new stake in shares of W.R. Berkley in the 1st quarter valued at approximately $41,000. Institutional investors and hedge funds own 68.82% of the company’s stock.

W.R. Berkley Company Profile

W. R. Berkley Corporation, an insurance holding company, operates as a commercial lines writers worldwide. It operates in two segments, Insurance and Reinsurance & Monoline Excess. The Insurance segment underwrites commercial insurance business, including excess and surplus lines, admitted lines, and specialty personal lines.